Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPELISIB vs ALPHA.-TOCOPHEROL, D-: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPELISIB vs ALPHA.-TOCOPHEROL, D-: Safety Overview

Metric ALPELISIB ALPHA.-TOCOPHEROL, D-
Total FAERS Reports 8,419 586
Deaths Reported 1,271 59
Death Rate 15.1% 10.1%
Hospitalizations 1,705 364
Average Patient Age 58.8 yrs 64.1 yrs
% Female Patients 94.7% 72.6%
FDA Approval Date Apr 24, 2024 N/A
Manufacturer Novartis Pharmaceuticals Corporation Bryant Ranch Prepack
Route ORAL ORAL
Marketing Status Prescription N/A